Evidence check: NutriCare | INFINITY DNA-Test in the context of menopause

The provided context does not include specific studies or validation data for the NutriCare or INFINITY DNA test in the context of menopause. In general, direct-to-consumer DNA tests for nutrition and health can indicate genetic predispositions, but effect sizes are typically small and often not validated for sex-specific conditions. Menopause is a hormonal transition driven by estrogen decline – a DNA test cannot measure or predict this process. Some tests market 'menopause scores' based on variants in hormone receptor genes, but the evidence is mechanistic or purely associative. Clinical markers such as FSH, estradiol, or symptom questionnaires are far more informative. Without independent clinical trials, the utility of such tests for menopause management remains unclear. Consumers should be cautious and not base medical decisions solely on these results. Evidence-based care involves clinical assessment and lifestyle adjustments under medical guidance.